Elizabeth Edwards Is Dead at 61
December 7, 2010 by Nancy
Filed under Featured Story
Courageous Elizabeth Edwards is dead at 61.
Ms. Edwards lost her 6 year battle with breast cancer today. She was the estranged wife of John Edwards, the former North Carolina senator and once hopeful presidential candidate.
It was announced on Monday that she had stopped all cancer treatment.
She recently posted a message on her Facebook page that read:
“You all know that I have been sustained throughout my life by three saving graces-my family, my friends, and a faith in the power of resilience and hope. These graces have carried me through difficult times and they have brought more joy to the good times than I ever could have imagined.”
Ms. Edwards endured her husband’s public infidelity with grace and dignity while at the same time maintaining her battle against cancer.
Her family said in a statement today, “Today we have lost the comfort of Elizabeth’s presence but she remains the heart of this family. We love her and will never know anyone more inspiring or full of life. On behalf of Elizabeth we want to express our gratitude to the thousands of kindred spirits who moved and inspired her along the way. Your support and prayers touched our entire family.”
Ms. Edwards wrote a best seller, “Saving Graces” about how trivial cancer seemed compared to the loss of her oldest son in 1996 from a car accident. He was 16.
Family, friends and her estranged husband were reportedly with her at her time of death. She is survived by 3 children.
A courageous Elizabeth Edwards is dead at 61 and will be greatly missed.
Findings do not Concur on Tamoxifen, Antidepressants and Breast Cancer Recurrence
May 31, 2009 by Nancy
Filed under Featured Story
Findings do not concur on two separate studies done to see if taking antidepressants interferes with the cancer prevention drug, tamoxifen’s ability to prevent breast cancer recurrence. Antidepressants are taken by breast cancer survivors to help with the hot flashes caused by tamoxifen.One study conducted by Medco Health Solutions of Franklin Lakes, N.J. showed that use of some antidepressants, mainly Prozac, Paxil and Zoloft, almost doubled the risk of breast cancer recurrence within two years after patients started tamoxifen.
Medco’s chief medical officer, Dr. Robert Epstein said, “no greater breast cancer risk was seen in women taking the antidepressants Celexa, Lexapro or Luvox with tamoxifen, and there are reasons to think that other antidepressants may be safe as well.”
In a second smaller study Dutch investigators reported just the opposite. They found no evidence that antidepressants increased the risk of breast cancer recurrence in women taking tamoxifen.
Both the Dutch and Medco studies were presented at a meeting of the American Society of Clinical Oncology. Both studies were based on a review of medical records, not a prospective clinical trial.
Since the findings do not concur on the recurrence of breast cancer while using tamoxifen and antidepressants, Dr. Claudine Isaacs, a breast specialist at Georgetown University’s Lombardi Comprehensive Cancer Center, advised,”until these data are absolutely clear, I would avoid drugs that impact on tamoxifen metabolism.”
Avon Walk for Breast Cancer Held in DC
May 4, 2009 by Nancy
Filed under Featured Story
Today marks the completion of the Avon Walk for Breast Cancer held in Washington, DC over the weekend. 39 miles in 2 days is the goal, with teams doing fundraising to raise money for research.
According to their website, the participants will “walk up to 26.2 miles on Saturday, and 13.1 miles on Sunday—all so that medically-underserved women and men can get the medical care they need and leading research teams can receive vital support for their ongoing search for a cure. The Avon Foundation places a priority on returning funds to the geographic area in which each Avon Walk takes place with a special emphasis on reaching low-income, elderly and minority individuals and those with inadequate health insurance.”
Support this great event by visiting their website to learn more.


